Saturday, 18 September 2021 05:20

CDC-led study ranks the 3 vaccines approved for use in US for effectiveness

Rate this item
(0 votes)

A head-to-head study of all three authorized coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer's in real-life use in keeping people out of the hospital, and Johnson & Johnson's Janssen vaccine comes in third, but still providing 71% protection.

Pfizer's vaccine provided 88% protection against hospitalization, and Moderna's was 93% effective.

The US Centers for Disease Control and Prevention led a nationwide study of vaccination involving more than 3,600 adults hospitalized for Covid-19 between March and August.

"Among U.S. adults without immunocompromising conditions, vaccine effectiveness against Covid-19 hospitalization during March 11--August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)," the team wrote in the CDC's weekly report on death and disease, the MMWR.

"Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

They found that the biggest difference between the vaccine made by Moderna and Pfizer/BioNtech's vaccine was driven by a decline that started about four months after people were fully vaccinated with Pfizer's vaccine.

"Differences in vaccine effectiveness between the Moderna and Pfizer-BioNTech vaccine might be due to higher mRNA content in the Moderna vaccine, differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna), or possible differences between groups that received each vaccine that were not accounted for in the analysis," the team wrote.

"A single dose of the Janssen viral vector vaccine had comparatively lower anti-SARS-CoV-2 antibody response and vaccine effectiveness against Covid-19 hospitalizations," they added.

"Understanding differences in vaccine effectiveness by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters. All FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

CDC worked with researchers across the country to study 3,689 patients at 21 hospitals in 18 states for the study. They also looked at antibodies in the blood of 100 healthy volunteers after they'd been vaccinated with one of the three available vaccines.

 

CNN

April 30, 2025

NNPCL faces criticism as Warri Refinery fails to take off after $897m in repairs bill

The Nigerian National Petroleum Company Limited is under scrutiny after the Warri Refining and Petrochemical…
April 28, 2025

Natasha mocks Akpabio in scathing ‘apology’ over sexual harassment claim

Suspended Kogi Central Senator Natasha Akpoti-Uduaghan on Sunday delivered a blistering, sarcastic "apology" to Senate…
April 29, 2025

How African popes changed Christianity - and gave the world Valentine's Day

Now predominantly Muslim, North Africa was once a Christian heartland, producing Catholic popes who left…
April 26, 2025

Declassified CIA file about UFO aliens attacking soldiers released

A declassified document posted to the CIA’s website is raising eyebrows with claims of an…
April 29, 2025

At least 26 people killed as 2 vehicles run over bomb planted by Boko Haram…

At least 26 people were killed on Monday when two vehicles detonated an improvised explosive…
April 30, 2025

Here’s the latest as Israel-Hamas war enters Day 572

UN chief urges 'irreversible action' on Israel, Palestinian two-state solution United Nations Secretary-General Antonio Guterres…
April 27, 2025

Smartphone use could reduce dementia risk in older adults, study finds

The first generation that has been exposed consistently to digital technology has reached the age…
January 08, 2025

NFF appoints new Super Eagles head coach

The Nigeria Football Federation (NFF) has appointed Éric Sékou Chelle as the new Head Coach…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2025 NewsScroll. All rights reserved.